Group 2 Innate Lymphoid Cells in the Regulation of Immune Responses

Advances in Immunology

Volumn 125, Issue 1, 2015, Pages 111-154

  Roediger, Ben ^a,b   Weninger, Wolfgang ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Eosinophil; ILC2 cell; Inflammation; Innate lymphoid cell; Interleukin 13; Interleukin 5; Mast cell; Skin; Th2 cell

Indexed keywords

AMPHIREGULIN; CELL SURFACE RECEPTOR; CRTH2 PROTEIN; CYTOKINE; DEATH RECEPTOR 3; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 25; INTERLEUKIN 25 RECEPTOR; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; INTERLEUKIN 9; INTERLEUKIN RECEPTOR; LEUKOTRIENE RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTEIN CYSLT1R; PROTEIN TL1A; RECEPTOR PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; THYMIC STROMAL LYMPHOPOIETIN RECEPTOR; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CYTOKINE PRODUCTION; DERMATITIS; GROUP 2 INNATE LYMPHOID CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOID CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN CELL; T LYMPHOCYTE; ANIMAL; CLASSIFICATION; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; MOUSE; TH2 CELL;

ANIMALS; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; LYMPHOCYTES; MICE; TH2 CELLS;

EID: 84922237105     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2014.09.004     Document Type: Chapter

References (224)

1. Abraham S.N., St John A.L. Mast cell-orchestrated immunity to pathogens. Nature Reviews. Immunology 2010, 10:440.
2. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nature Reviews. Immunology 2002, 2:410.
3. Ali S., Mohs A., Thomas M., Klare J., Ross R., Schmitz M.L., et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. Journal of Immunology 2011, 187:1609.
4. Allakhverdi Z., Comeau M.R., Jessup H.K., Yoon B.R., Brewer A., Chartier S., et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. The Journal of Experimental Medicine 2007, 204:253.
5. Ando T., Matsumoto K., Namiranian S., Yamashita H., Glatthorn H., Kimura M., et al. Mast cells are required for full expression of allergen/SEB-induced skin inflammation. The Journal of Investigative Dermatology 2013, 133:2695.
6. Ando T., Xiao W., Gao P., Namiranian S., Matsumoto K., Tomimori Y., et al. Critical role for mast cell Stat5 activity in skin inflammation. Cell Reports 2014, 6:366.
7. Andrews A.L., Nordgren I.K., Kirby I., Holloway J.W., Holgate S.T., Davies D.E., et al. Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transduction. Biochemical Society Transactions 2009, 37:873.
8. Angkasekwinai P., Chang S.H., Thapa M., Watarai H., Dong C. Regulation of IL-9 expression by IL-25 signaling. Nature Immunology 2010, 11:250.
9. Avni O., Lee D., Macian F., Szabo S.J., Glimcher L.H., Rao A. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunology 2002, 3:643.
10. Baccala R., Witherden D., Gonzalez-Quintial R., Dummer W., Surh C.D., Havran W.L., et al. Gamma delta T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. Journal of Immunology 2005, 174:4606.
11. Barlow J.L., Bellosi A., Hardman C.S., Drynan L.F., Wong S.H., Cruickshank J.P., et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. The Journal of Allergy and Clinical Immunology 2012, 129:191.
12. Barlow J.L., Peel S., Fox J., Panova V., Hardman C.S., Camelo A., et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. The Journal of Allergy and Clinical Immunology 2013, 132:933.
13. Barnig C., Cernadas M., Dutile S., Liu X., Perrella M.A., Kazani S., et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Science Translational Medicine 2013, 5:174ra26.
14. Bartemes K.R., Iijima K., Kobayashi T., Kephart G.M., McKenzie A.N., Kita H. IL-33-responsive lineage-CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. Journal of Immunology 2012, 188:1503.
15. Bell B.D., Kitajima M., Larson R.P., Stoklasek T.A., Dang K., Sakamoto K., et al. The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses. Nature Immunology 2013, 14:364.
16. Bernink J.H., Peters C.P., Munneke M., te Velde A.A., Meijer S.L., Weijer K., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nature Immunology 2013, 14:221.
17. Bieber T. Atopic dermatitis. The New England Journal of Medicine 2008, 358:1483.
18. Bogiatzi S.I., Fernandez I., Bichet J.C., Marloie-Provost M.A., Volpe E., Sastre X., et al. Cutting edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. Journal of Immunology 2007, 178:3373.
19. Boitano S., Flynn A.N., Sherwood C.L., Schulz S.M., Hoffman J., Gruzinova I., et al. Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2. American Journal of Physiology. Lung Cellular and Molecular Physiology 2011, 300:L605.
20. Boyman O., Kovar M., Rubinstein M.P., Surh C.D., Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 2006, 311:1924.
21. Brossard M., Wikel S.K. Tick immunobiology. Parasitology 2004, 129(Suppl.):S161.
22. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science 1996, 272:60.
23. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:282.
24. Casolaro V., Georas S.N., Song Z., Zubkoff I.D., Abdulkadir S.A., Thanos D., et al. Inhibition of NF-AT-dependent transcription by NF-kappa B: Implications for differential gene expression in T helper cell subsets. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:11623.
25. Chang Y.J., DeKruyff R.H., Umetsu D.T. The role of type 2 innate lymphoid cells in asthma. Journal of Leukocyte Biology 2013, 94:933.
26. Chang Y.J., Kim H.Y., Albacker L.A., Baumgarth N., McKenzie A.N., Smith D.E., et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nature Immunology 2011, 12:631.
27. Chinnaiyan A.M., O'Rourke K., Yu G.L., Lyons R.H., Garg M., Duan D.R., et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996, 274:990.
28. Chu V.T., Frohlich A., Steinhauser G., Scheel T., Roch T., Fillatreau S., et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nature Immunology 2011, 12:151.
29. Commins S.P., James H.R., Kelly L.A., Pochan S.L., Workman L.J., Perzanowski M.S., et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose. The Journal of Allergy and Clinical Immunology 2011, 127:1286.
30. Constantinides M.G., McDonald B.D., Verhoef P.A., Bendelac A. A committed precursor to innate lymphoid cells. Nature 2014, 508:397.
31. Crellin N.K., Trifari S., Kaplan C.D., Satoh-Takayama N., Di Santo J.P., Spits H. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010, 33:752.
32. Cron R.Q., Bort S.J., Wang Y., Brunvand M.W., Lewis D.B. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells. Journal of Immunology 1999, 162:860.
33. Dent L.A., Strath M., Mellor A.L., Sanderson C.J. Eosinophilia in transgenic mice expressing interleukin 5. The Journal of Experimental Medicine 1990, 172:1425.
34. Doherty T.A., Khorram N., Chang J.E., Kim H.K., Rosenthal P., Croft M., et al. STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. American Journal of Physiology. Lung Cellular and Molecular Physiology 2012, 303:L577.
35. Doherty T.A., Khorram N., Lund S., Mehta A.K., Croft M., Broide D.H. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. The Journal of Allergy and Clinical Immunology 2013, 132:205.
36. Dyring-Andersen B., Geisler C., Agerbeck C., Lauritsen J.P., Gudjonsdottir S.D., Skov L., et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. The British Journal of Dermatology 2014, 170:609.
37. Erickson L.D., Foy T.M., Waldschmidt T.J. Murine B1 B cells require IL-5 for optimal T cell-dependent activation. Journal of Immunology 2001, 166:1531.
38. Fichtner-Feigl S., Strober W., Kawakami K., Puri R.K., Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nature Medicine 2006, 12:99.
39. Flohr C., Perkin M., Logan K., Marrs T., Radulovic S., Campbell L.E., et al. Atopic dermatitis and disease severity are the main risk factors for food sensitization in exclusively breastfed infants. The Journal of Investigative Dermatology 2014, 134:345.
40. Forbes E.E., Groschwitz K., Abonia J.P., Brandt E.B., Cohen E., Blanchard C., et al. IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. The Journal of Experimental Medicine 2008, 205:897.
41. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 15:985.
42. Fuchs A., Vermi W., Lee J.S., Lonardi S., Gilfillan S., Newberry R.D., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-gamma-producing cells. Immunity 2013, 38:769.
43. Gao P.S., Rafaels N.M., Mu D., Hand T., Murray T., Boguniewicz M., et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. The Journal of Allergy and Clinical Immunology 2010, 125:1403.
44. Gaytan F., Martinez-Fuentes A.J., Garcia-Navarro F., Vaudry H., Aguilar E. Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell and Tissue Research 1994, 276:223.
45. Gold M.J., Antignano F., Halim T.Y., Hirota J.A., Blanchet M.R., Zaph C., et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. The Journal of Allergy and Clinical Immunology 2014, 133:1142.
46. Gordon S.M., Chaix J., Rupp L.J., Wu J., Madera S., Sun J.C., et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012, 36:55.
47. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998, 282:2261.
48. Guimond M., Veenstra R.G., Grindler D.J., Zhang H., Cui Y., Murphy R.D., et al. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nature Immunology 2009, 10:149.
49. Guo L., Junttila I.S., Paul W.E. Cytokine-induced cytokine production by conventional and innate lymphoid cells. Trends in Immunology 2012, 33:598.
50. Guo L., Wei G., Zhu J., Liao W., Leonard W.J., Zhao K., et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:13463.
51. Halim T.Y., Krauss R.H., Sun A.C., Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012, 36:451.
52. Halim T.Y., MacLaren A., Romanish M.T., Gold M.J., McNagny K.M., Takei F. Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 2012, 37:463.
53. Halim T.Y., Steer C.A., Matha L., Gold M.J., Martinez-Gonzalez I., McNagny K.M., et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014, 40:425.
54. Hamid Q., Boguniewicz M., Leung D.Y. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. The Journal of Clinical Investigation 1994, 94:870.
55. Hammad H., Chieppa M., Perros F., Willart M.A., Germain R.N., Lambrecht B.N. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nature Medicine 2009, 15:410.
56. Hams E., Armstrong M.E., Barlow J.L., Saunders S.P., Schwartz C., Cooke G., et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:367.
57. Hanke T., Corral L., Vance R.E., Raulet D.H. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. European Journal of Immunology 1998, 28:4409.
58. Hardy R.R., Hayakawa K. B cell development pathways. Annual Review of Immunology 2001, 19:595.
59. He R., Kim H.Y., Yoon J., Oyoshi M.K., MacGinnitie A., Goya S., et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. The Journal of Allergy and Clinical Immunology 2009, 124:761.
60. Henson S.M., Akbar A.N. KLRG1-More than a marker for T cell senescence. Age 2009, 31:285.
61. Henson S.M., Franzese O., Macaulay R., Libri V., Azevedo R.I., Kiani-Alikhan S., et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 2009, 113:6619.
62. Hepworth M.R., Monticelli L.A., Fung T.C., Ziegler C.G., Grunberg S., Sinha R., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013, 498:113.
63. Heredia J.E., Mukundan L., Chen F.M., Mueller A.A., Deo R.C., Locksley R.M., et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013, 153:376.
64. Hershey G.K. IL-13 receptors and signaling pathways: An evolving web. The Journal of Allergy and Clinical Immunology 2003, 111:677.
65. Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nature Immunology 2011, 12:255.
66. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006, 24:341.
67. Hoyler T., Klose C.S., Souabni A., Turqueti-Neves A., Pfeifer D., Rawlins E.L., et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012, 37:634.
68. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
69. Hung L.Y., Lewkowich I.P., Dawson L.A., Downey J., Yang Y., Smith D.E., et al. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:282.
70. Ikeda K., Nakajima H., Suzuki K., Kagami S., Hirose K., Suto A., et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003, 101:3594.
71. Imai Y., Yasuda K., Sakaguchi Y., Haneda T., Mizutani H., Yoshimoto T., et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:13921.
72. Iordanov M.S., Sundholm A.J., Simpson E.L., Hanifin J.M., Ryabinina O.P., Choi R.J., et al. Cell death-induced activation of epidermal growth factor receptor in keratinocytes: Implications for restricting epidermal damage in dermatitis. The Journal of Investigative Dermatology 2005, 125:134.
73. Iwakura Y., Ishigame H., Saijo S., Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011, 34:149.
74. Jabeen R., Kaplan M.H. The symphony of the ninth: The development and function of Th9 cells. Current Opinion in Immunology 2012, 24:303.
75. Jeong S.K., Kim H.J., Youm J.K., Ahn S.K., Choi E.H., Sohn M.H., et al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. The Journal of Investigative Dermatology 2008, 128:1930.
76. Junttila I.S., Watson C., Kummola L., Chen X., Hu-Li J., Guo L., et al. Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3. The Journal of Allergy and Clinical Immunology 2013, 132:704.
77. Kabata H., Moro K., Fukunaga K., Suzuki Y., Miyata J., Masaki K., et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nature Communications 2013, 4:2675.
78. Kaiko G.E., Loh Z., Spann K., Lynch J.P., Lalwani A., Zheng Z., et al. Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. The Journal of Allergy and Clinical Immunology 2013, 131:1331.
79. Kanaoka Y., Boyce J.A. Cysteinyl leukotrienes and their receptors: Cellular distribution and function in immune and inflammatory responses. Journal of Immunology 2004, 173:1503.
80. Kaplan M.H., Daniel C., Schindler U., Grusby M.J. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Molecular and Cellular Biology 1998, 18:1996.
81. Kaviratne M., Hesse M., Leusink M., Cheever A.W., Davies S.J., McKerrow J.H., et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. Journal of Immunology 2004, 173:4020.
82. Kim H.Y., Chang Y.J., Subramanian S., Lee H.H., Albacker L.A., Matangkasombut P., et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. The Journal of Allergy and Clinical Immunology 2012, 129:216.
83. Kim B.S., Siracusa M.C., Saenz S.A., Noti M., Monticelli L.A., Sonnenberg G.F., et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Science Translational Medicine 2013, 5:170ra16.
84. Klein Wolterink R.G., Kleinjan A., van Nimwegen M., Bergen I., de Bruijn M., Levani Y., et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. European Journal of Immunology 2012, 42:1106.
85. Klose C.S., Flach M., Mohle L., Rogell L., Hoyler T., Ebert K., et al. Differentiation of Type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014, 157:340.
86. Klose C.S., Kiss E.A., Schwierzeck V., Ebert K., Hoyler T., d'Hargues Y., et al. A T-bet gradient controls the fate and function of CCR6-RORgammat+innate lymphoid cells. Nature 2013, 494:261.
87. Kolodsick J.E., Toews G.B., Jakubzick C., Hogaboam C., Moore T.A., McKenzie A., et al. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. Journal of Immunology 2004, 172:4068.
88. Kopf M., Brombacher F., Hodgkin P.D., Ramsay A.J., Milbourne E.A., Dai W.J., et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996, 4:15.
89. Kouzaki H., Iijima K., Kobayashi T., O'Grady S.M., Kita H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. Journal of Immunology 2011, 186:4375.
90. Kurashima Y., Amiya T., Fujisawa K., Shibata N., Suzuki Y., Kogure Y., et al. The enzyme cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis. Immunity 2014, 40:530.
91. Lee J.S., Cella M., McDonald K.G., Garlanda C., Kennedy G.D., Nukaya M., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nature Immunology 2012, 13:144.
92. Lee H.J., Takemoto N., Kurata H., Kamogawa Y., Miyatake S., O'Garra A., et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. The Journal of Experimental Medicine 2000, 192:105.
93. Liang H.E., Reinhardt R.L., Bando J.K., Sullivan B.M., Ho I.C., Locksley R.M. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nature Immunology 2012, 13:58.
94. Liao W., Spolski R., Li P., Du N., West E.E., Ren M., et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:3508.
95. Licona-Limon P., Henao-Mejia J., Temann A.U., Gagliani N., Licona-Limon I., Ishigame H., et al. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 2013, 39:744.
96. Licona-Limon P., Kim L.K., Palm N.W., Flavell R.A. TH2, allergy and group 2 innate lymphoid cells. Nature Immunology 2013, 14:536.
97. Lischke A., Moriggl R., Brandlein S., Berchtold S., Kammer W., Sebald W., et al. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. The Journal of Biological Chemistry 1998, 273:31222.
98. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., Vadas M.A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. The Journal of Experimental Medicine 1988, 167:219.
99. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nature Immunology 2009, 10:75.
100. Luthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84.
101. Ma L., Xue H.B., Guan X.H., Shu C.M., Zhang J.H., Yu J. Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clinical and Experimental Immunology 2014, 175:25.
102. Maki K., Sunaga S., Komagata Y., Kodaira Y., Mabuchi A., Karasuyama H., et al. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:7172.
103. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annual Review of Immunology 2009, 27:451.
104. Mebius R.E. Organogenesis of lymphoid tissues. Nature Reviews. Immunology 2003, 3:292.
105. Mebius R.E., Rennert P., Weissman I.L. Developing lymph nodes collect CD4+ CD3-LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997, 7:493.
106. Mellor E.A., Maekawa A., Austen K.F., Boyce J.A. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:7964.
107. Mentink-Kane M.M., Wynn T.A. Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunological Reviews 2004, 202:191.
108. Meylan F., Hawley E.T., Barron L., Barlow J.L., Penumetcha P., Pelletier M., et al. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunology 2014, 7:958-968.
109. Mielke L.A., Groom J.R., Rankin L.C., Seillet C., Masson F., Putoczki T., et al. TCF-1 controls ILC2 and NKp46+RORgammat+ innate lymphocyte differentiation and protection in intestinal inflammation. Journal of Immunology 2013, 191:4383.
110. Mielke L.A., Jones S.A., Raverdeau M., Higgs R., Stefanska A., Groom J.R., et al. Retinoic acid expression associates with enhanced IL-22 production by gammadelta T cells and innate lymphoid cells and attenuation of intestinal inflammation. The Journal of Experimental Medicine 2013, 210:1117.
111. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479.
112. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248.
113. Mirchandani A.S., Besnard A.G., Yip E., Scott C., Bain C.C., Cerovic V., et al. Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. Journal of Immunology 2014, 192:2442.
114. Mishra A., Rothenberg M.E. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003, 125:1419.
115. Miyata M., Nakamura Y., Shimokawa N., Ohnuma Y., Katoh R., Matsuoka S., et al. Thymic stromal lymphopoietin is a critical mediator of IL-13-driven allergic inflammation. European Journal of Immunology 2009, 39:3078.
116. Mjosberg J., Bernink J., Golebski K., Karrich J.J., Peters C.P., Blom B., et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012, 37:649.
117. Mjosberg J.M., Trifari S., Crellin N.K., Peters C.P., van Drunen C.M., Piet B., et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nature Immunology 2011, 12:1055.
118. Mohrs M., Shinkai K., Mohrs K., Locksley R.M. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 2001, 15:303.
119. Molofsky A.B., Nussbaum J.C., Liang H.E., Van Dyken S.J., Cheng L.E., Mohapatra A., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. The Journal of Experimental Medicine 2013, 210:535.
120. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G., Doering T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nature Immunology 2011, 12:1045.
121. Moriggl R., Sexl V., Piekorz R., Topham D., Ihle J.N. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 1999, 11:225.
122. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999, 10:249.
123. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540.
124. Motomura Y., Morita H., Moro K., Nakae S., Artis D., Endo T.A., et al. Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity 2014, 40:758.
125. Naik S., Billington C.K., Pascual R.M., Deshpande D.A., Stefano F.P., Kohout T.A., et al. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. The Journal of Biological Chemistry 2005, 280:8722.
126. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367.
127. Newcomb D.C., Boswell M.G., Huckabee M.M., Goleniewska K., Dulek D.E., Reiss S., et al. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. Journal of Immunology 2012, 188:1027.
128. Newcomb D.C., Zhou W., Moore M.L., Goleniewska K., Hershey G.K., Kolls J.K., et al. A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production. Journal of Immunology 2009, 182:5317.
129. Ng S.W., Bakowski D., Nelson C., Mehta R., Almeyda R., Bates G., et al. Cysteinyl leukotriene type I receptor desensitization sustains Ca2+-dependent gene expression. Nature 2012, 482:111.
130. Noti M., Wojno E.D., Kim B.S., Siracusa M.C., Giacomin P.R., Nair M.G., et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nature Medicine 2013, 19:1005.
131. Nussbaum J.C., Van Dyken S.J., von Moltke J., Cheng L.E., Mohapatra A., Molofsky A.B., et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013, 502:245.
132. Oboki K., Ohno T., Kajiwara N., Arae K., Morita H., Ishii A., et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:18581.
133. Odum L., Petersen L.J., Skov P.S., Ebskov L.B. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells. Inflammation Research: Official Journal of the European Histamine Research Society 1998, 47:488-492.
134. Okano J., Lichti U., Mamiya S., Aronova M., Zhang G., Yuspa S.H., et al. Increased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal development. Journal of Cell Science 2012, 125:1827.
135. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. The New England Journal of Medicine 2002, 347:1151.
136. Oyoshi M.K., Larson R.P., Ziegler S.F., Geha R.S. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. The Journal of Allergy and Clinical Immunology 2010, 126:976.
137. Pearce E.L., Mullen A.C., Martins G.A., Krawczyk C.M., Hutchins A.S., Zediak V.P., et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 2003, 302:1041.
138. Peterson L.W., Artis D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nature Reviews. Immunology 2014, 14:141.
139. Polumuri S.K., Jayakar G.G., Shirey K.A., Roberts Z.J., Perkins D.J., Pitha P.M., et al. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. Journal of Immunology 2012, 189:50.
140. Pope S.M., Brandt E.B., Mishra A., Hogan S.P., Zimmermann N., Matthaei K.I., et al. IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism. The Journal of Allergy and Clinical Immunology 2001, 108:594.
141. Possot C., Schmutz S., Chea S., Boucontet L., Louise A., Cumano A., et al. Notch signaling is necessary for adult, but not fetal, development of RORgammat(+) innate lymphoid cells. Nature Immunology 2011, 12:949.
142. Prehn J.L., Thomas L.S., Landers C.J., Yu Q.T., Michelsen K.S., Targan S.R. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. Journal of Immunology 2007, 178:4033.
143. Price A.E., Liang H.E., Sullivan B.M., Reinhardt R.L., Eisley C.J., Erle D.J., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11489.
144. Qi X., Nishida J., Chaves L., Ohmori K., Huang H. CCAAT/enhancer-binding protein alpha (C/EBPalpha) is critical for interleukin-4 expression in response to FcepsilonRI receptor cross-linking. The Journal of Biological Chemistry 2011, 286:16063.
145. Rankin A.L., Mumm J.B., Murphy E., Turner S., Yu N., McClanahan T.K., et al. IL-33 induces IL-13-dependent cutaneous fibrosis. Journal of Immunology 2010, 184:1526.
146. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: Regulation and function. Annual Review of Immunology 1997, 15:707.
147. Rasko J.E., Metcalf D., Rossner M.T., Begley C.G., Nicola N.A. The flt3/flk-2 ligand: Receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 1995, 9:2058.
148. Roediger B., Kyle R., Yip K.H., Sumaria N., Guy T.V., Kim B.S., et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nature Immunology 2013, 14:564.
149. Rosenberg H.F., Dyer K.D., Foster P.S. Eosinophils: Changing perspectives in health and disease. Nature Reviews. Immunology 2013, 13:9.
150. Rosshart S., Hofmann M., Schweier O., Pfaff A.K., Yoshimoto K., Takeuchi T., et al. Interaction of KLRG1 with E-cadherin: New functional and structural insights. European Journal of Immunology 2008, 38:3354.
151. Russell L., Garrett-Sinha L.A. Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 2010, 51:217.
152. Saenz S.A., Siracusa M.C., Monticelli L.A., Ziegler C.G., Kim B.S., Brestoff J.R., et al. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. The Journal of Experimental Medicine 2013, 210:1823.
153. Salimi M., Barlow J.L., Saunders S.P., Xue L., Gutowska-Owsiak D., Wang X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. The Journal of Experimental Medicine 2013, 210:2939.
154. Salmond R.J., Mirchandani A.S., Besnard A.G., Bain C.C., Thomson N.C., Liew F.Y. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. The Journal of Allergy and Clinical Immunology 2012, 130:1159.
155. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nature Immunology 2009, 10:83.
156. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich C.A., et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. The Journal of Experimental Medicine 2010, 207:273.
157. Schlapbach C., Gehad A., Yang C., Watanabe R., Guenova E., Teague J.E., et al. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Science Translational Medicine 2014, 6:219ra8.
158. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479.
159. Schwartzkopff S., Grundemann C., Schweier O., Rosshart S., Karjalainen K.E., Becker K.F., et al. Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans. Journal of Immunology 2007, 179:1022.
160. Serafini N., Klein Wolterink R.G., Satoh-Takayama N., Xu W., Vosshenrich C.A., Hendriks R.W., et al. Gata3 drives development of RORgammat+ group 3 innate lymphoid cells. The Journal of Experimental Medicine 2014, 211:199.
161. Serhan C.N. Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual Review of Immunology 2007, 25:101.
162. Shaw J.L., Fakhri S., Citardi M.J., Porter P.C., Corry D.B., Kheradmand F., et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. American Journal of Respiratory and Critical Care Medicine 2013, 188:432.
163. Sheward W.J., Maywood E.S., French K.L., Horn J.M., Hastings M.H., Seckl J.R., et al. Entrainment to feeding but not to light: Circadian phenotype of VPAC2 receptor-null mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:4351.
164. Sivaprasad U., Warrier M.R., Gibson A.M., Chen W., Tabata Y., Bass S.A., et al. IL-13Ralpha2 has a protective role in a mouse model of cutaneous inflammation. Journal of Immunology 2010, 185:6802.
165. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunology 2002, 3:673.
166. Spencer S.P., Wilhelm C., Yang Q., Hall J.A., Bouladoux N., Boyd A., et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 2014, 343:432.
167. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nature Reviews. Immunology 2013, 13:145.
168. Spits H., Cupedo T. Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annual Review of Immunology 2012, 30:647.
169. Spooner C.J., Lesch J., Yan D., Khan A.A., Abbas A., Ramirez-Carrozzi V., et al. Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nature Immunology 2013, 14:1229.
170. Strempel J.M., Grenningloh R., Ho I.C., Vercelli D. Phylogenetic and functional analysis identifies Ets-1 as a novel regulator of the Th2 cytokine gene locus. Journal of Immunology 2010, 184:1309.
171. Sumaria N., Roediger B., Ng L.G., Qin J., Pinto R., Cavanagh L.L., et al. Cutaneous immunosurveillance by self-renewing dermal gammadelta T cells. The Journal of Experimental Medicine 2011, 208:505.
172. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000, 288:2369.
173. Suzuki K., Nakajima H., Watanabe N., Kagami S., Suto A., Saito Y., et al. Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells. Blood 2000, 96:2172.
174. Teunissen M.B., Munneke J.M., Bernink J.H., Spuls P.I., Res P.C., Te Velde A., et al. Composition of innate lymphoid cell subsets in the human skin: Enrichment of NCR ILC3 in lesional skin and blood of psoriasis patients. The Journal of Investigative Dermatology 2014, 134:2351-2360.
175. Todd M.D., Grusby M.J., Lederer J.A., Lacy E., Lichtman A.H., Glimcher L.H. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. The Journal of Experimental Medicine 1993, 177:1663.
176. Townsend M.J., Fallon P.G., Matthews D.J., Jolin H.E., McKenzie A.N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. The Journal of Experimental Medicine 2000, 191:1069.
177. Townsend J.M., Fallon G.P., Matthews J.D., Smith P., Jolin E.H., McKenzie N.A. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000, 13:573.
178. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004, 20:477.
179. Turner J.E., Morrison P.J., Wilhelm C., Wilson M., Ahlfors H., Renauld J.C., et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. The Journal of Experimental Medicine 2013, 210:2951.
180. Ullah M.A., Loh Z., Gan W.J., Zhang V., Yang H., Li J.H., et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. The Journal of Allergy and Clinical Immunology 2014, 134:440-450.
181. van den Oord R.A., Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: Systematic review and meta-analysis. BMJ 2009, 339:b2433.
182. Van Dyken S.J., Locksley R.M. Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: Roles in homeostasis and disease. Annual Review of Immunology 2013, 31:317.
183. Van Dyken S.J., Mohapatra A., Nussbaum J.C., Molofsky A.B., Thornton E.E., Ziegler S.F., et al. Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and gammadelta T cells. Immunity 2014, 40:414.
184. Vassiliou E., Jiang X., Delgado M., Ganea D. TH2 lymphocytes secrete functional VIP upon antigen stimulation. Archives of Physiology and Biochemistry 2001, 109:365.
185. Vaudry D., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacological Reviews 2009, 61:283.
186. Vella A.T., Dow S., Potter T.A., Kappler J., Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:3810.
187. Villanova F., Flutter B., Tosi I., Grys K., Sreeneebus H., Perera G.K., et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. The Journal of Investigative Dermatology 2014, 134:984.
188. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010, 33:736.
189. Walker J.A., Barlow J.L., McKenzie A.N. Innate lymphoid cells-How did we miss them?. Nature Reviews. Immunology 2013, 13:75.
190. Wikel S.K. Host immunity to ticks. Annual Review of Entomology 1996, 41:1.
191. Wilhelm C., Hirota K., Stieglitz B., Van Snick J., Tolaini M., Lahl K., et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nature Immunology 2011, 12:1071.
192. Wilhelm C., Turner J.E., Van Snick J., Stockinger B. The many lives of IL-9: A question of survival?. Nature Immunology 2012, 13:637.
193. Willart M.A., Deswarte K., Pouliot P., Braun H., Beyaert R., Lambrecht B.N., et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. The Journal of Experimental Medicine 2012, 209:1505.
194. Wills-Karp M. Allergen-specific pattern recognition receptor pathways. Current Opinion in Immunology 2010, 22:777.
195. Wills-Karp M., Finkelman F.D. Untangling the complex web of IL-4-and IL-13-mediated signaling pathways. Science Signaling 2008, 1:pe55.
196. Wills-Karp M., Rani R., Dienger K., Lewkowich I., Fox J.G., Perkins C., et al. Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. The Journal of Experimental Medicine 2012, 209:607.
197. Wong S.H., Walker J.A., Jolin H.E., Drynan L.F., Hams E., Camelo A., et al. Transcription factor RORalpha is critical for nuocyte development. Nature Immunology 2012, 13:229.
198. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243.
199. Wurster A.L., Withers D.J., Uchida T., White M.F., Grusby M.J. Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Molecular and Cellular Biology 2002, 22:117.
200. Wynn T.A. IL-13 effector functions. Annual Review of Immunology 2003, 21:425.
201. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nature Reviews. Immunology 2004, 4:583.
202. Wynn T.A. Integrating mechanisms of pulmonary fibrosis. The Journal of Experimental Medicine 2011, 208:1339.
203. Xue L., Barrow A., Pettipher R. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. Journal of Immunology 2009, 182:7580.
204. Xue L., Salimi M., Panse I., Mjosberg J.M., McKenzie A.N., Spits H., et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. The Journal of Allergy and Clinical Immunology 2014, 133:1184.
205. Yagi R., Zhong C., Northrup D.L., Yu F., Bouladoux N., Spencer S., et al. The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells. Immunity 2014, 40:378.
206. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. The Journal of Experimental Medicine 1988, 167:1737.
207. Yang Q., Monticelli L.A., Saenz S.A., Chi A.W., Sonnenberg G.F., Tang J., et al. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 2013, 38:694.
208. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29.
209. Yao W., Zhang Y., Jabeen R., Nguyen E.T., Wilkes D.S., Tepper R.S., et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013, 38:360.
210. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999, 397:702.
211. Yu X., Pappu R., Ramirez-Carrozzi V., Ota N., Caplazi P., Zhang J., et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunology 2014, 7:730.
212. Zabel B.A., Agace W.W., Campbell J.J., Heath H.M., Parent D., Roberts A.I., et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. The Journal of Experimental Medicine 1999, 190:1241.
213. Zaiss D.M., Yang L., Shah P.R., Kobie J.J., Urban J.F., Mosmann T.R. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science 2006, 314:1746.
214. Zaph C., Du Y., Saenz S.A., Nair M.G., Perrigoue J.G., Taylor B.C., et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. The Journal of Experimental Medicine 2008, 205:2191.
215. Zhang Z., Hener P., Frossard N., Kato S., Metzger D., Li M., et al. Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1536.
216. Zhang L., Lu R., Zhao G., Pflugfelder S.C., Li D.Q. TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. The International Journal of Biochemistry & Cell Biology 2011, 43:1383.
217. Zheng T., Oh M.H., Oh S.Y., Schroeder J.T., Glick A.B., Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. The Journal of Investigative Dermatology 2009, 129:742.
218. Zheng T., Yu J., Oh M.H., Zhu Z. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. Allergy, Asthma & Immunology Research 2011, 3:67.
219. Zhou L. Striking similarity: GATA-3 regulates ILC2 and Th2 cells. Immunity 2012, 37:589.
220. Zhou B., Comeau M.R., De Smedt T., Liggitt H.D., Dahl M.E., Lewis D.B., et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nature Immunology 2005, 6:1047.
221. Zhu J., Guo L., Min B., Watson C.J., Hu-Li J., Young H.A., et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 2002, 16:733.
222. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. The Journal of Clinical Investigation 1999, 103:779.
223. Zhu Z., Oh M.H., Yu J., Liu Y.J., Zheng T. The role of TSLP in IL-13-induced atopic march. Scientific Reports 2011, 1:23.
224. Ziegler S.F. Thymic stromal lymphopoietin and allergic disease. The Journal of Allergy and Clinical Immunology 2012, 130:845.